Table 1.
Reference | Resection | Study Design b | Study Period | MI Approach (%) | Patients (n) | AL (n) | N CRT (n) | Marker Type | Biomarkers |
---|---|---|---|---|---|---|---|---|---|
Asti et al. [32] | Esophageal | Retrospective | 2012–2017 | 100 | 243 | 29 | 96 | Serum | CRP, PCT, leucocytes and PN |
Baker et al. [33] | Esophageal | Retrospective | 2009–2014 | 93 | 100 | 13 | 68 | Serum and drain | Amylase and leucocytes |
Berkelmans et al. [47] | Esophageal | Retrospective | 2013–2014 | 100 | 89 | 15 | 84 | Drain | Amylase |
Dutta et al. [34] | Esophagogastric | Retrospective | 2005–2009 | NR | 136 | 17 | 80 | Serum | CRP |
Edagawa et al. [44] | Esophageal | Retrospective | 2007–2009 | 66 | 204 | 44 | NR | Serum | CRP, FIB |
Ellebaek et al. [53] | Esophagogastric | Prospective | 2006–2010 | 0 | 54 | 7 | 29 | Mediastinal microdialysis | Lactate, pyruvate, glucose, glycerol a and pyrovate |
Findlay et al. [35] | Esophagogastric | Retrospective | 2008–2013 | 0 | 248 | 21 | 189 | Serum and drain | CRP a, leucocytes, albumin a and NUn score |
Gao et al. [45] | Esophageal | Retrospective | 2016–2017 | 100 | 96 | 12 | 38 | Serum and drain | Amylase and prealbumin |
Giulini et al. [46] | Esophageal | Retrospective | 2015–2017 | 64 | 80 | 6 | 40 | Serum and drain | Amylase and CRP |
Gordon et al. [36] | Esophagogastric | Retrospective | 2004–2014 | 0 | 145 | 13 | NR | Serum | CRP |
Hoeboer et al. [37] | Esophageal | Prospective | 2011–2012 | 10 | 45 | 10 | 40 | Serum | CRP, PCT and leucocytes a |
Ip et al. [38] | Esophageal | Retrospective | 2012–2014 | 7 | 136 | 18 | 70 | Serum | Lactate |
Ji et al. [39] | Esophagogastric | Retrospective | 2014 | 0 | 97 | 10 | NR | Serum | CRP |
Li et al. [40] | Esophageal | Retrospective | 2013–2016 | 8 | 71 | 47 | 5 | Serum and respiratory | CRP a, PCT, leucocytes a, albumin, Hb a, PLT a, BG, pO2 a and fiO2 a |
Machens et al. [48] | Esophageal | Retrospective | 1992–1994 | 0 | 26 | 14 | NR | Drain | amylase and ph a |
Miller et al. [55] | Esophageal | Retospective | 2015–2016 | 100 | 45 | 3 | 27 | Drain | Amylase |
Noble et al. [41] | Esophageal | Retrospective | 2005–2011 | NR | 258 | 26 | 156 | Serum and score | CRP, leucocytes, albumin and NUn score |
Paireder et al. [52] | Esophageal | Retrospective | 2003–2014 | 28 | 258 | 32 | 177 | Score | NUn score |
Park et al. [42] | Esophageal | Retrospective | 2009–2016 | 56 | 201 | 23 | 45 | Serum | CRP and leucocytes a |
Perry et al. [49] | Esophageal | Retrospective | 2007–2014 | 58 | 146 | 35 | NR | Drain | Amylase |
Plat et al. [54] | Esophageal | Prospective | 2015–2016 | NR | 31 | 9 | 29 | Urine | VOC |
Schots et al. [50] | Gastric | Retrospective | 2013–2017 | 70 | 107 | 8 | 71 | Drain | Amylase and CRP a |
Song et al. [43] | Esophageal | Retrospective | 2015–2016 | 67 | 183 | 16 | 50 | Plasma | TNF-, IL-2R, IL-6, IL-8 and IL-10 |
Yu et al. [51] | Esophageal | Retrospective | 2014–2017 | NR | 99 | 10 | 17 | Drain | Amylase |
a Statistical significance for detection AL not proven; b All studies include surgical resection for cancer and were mainly elective. AL, anastomotic leakage; NR, not reported, nCRT, neo-adjuvant chemoradiation therapy; MI, minimally invasive; CRP, C-reactive protein; PCT, procalcitonin; PN, per cent neutrophils; NUn score, 11.3894 + 0.005 (CRP) + 0186 (WCC) − 0.174 (Albumin); Hb, haemoglobin; PLT, platelet; BG, blood antigenemia; IL, interleukin.